Cathy Eng

26.1k total citations · 10 hit papers
409 papers, 16.2k citations indexed

About

Cathy Eng is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cathy Eng has authored 409 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 291 papers in Oncology, 179 papers in Surgery and 135 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cathy Eng's work include Colorectal Cancer Treatments and Studies (195 papers), Colorectal and Anal Carcinomas (128 papers) and Gastric Cancer Management and Outcomes (74 papers). Cathy Eng is often cited by papers focused on Colorectal Cancer Treatments and Studies (195 papers), Colorectal and Anal Carcinomas (128 papers) and Gastric Cancer Management and Outcomes (74 papers). Cathy Eng collaborates with scholars based in United States, Italy and Spain. Cathy Eng's co-authors include Scott Kopetz, George J. Chang, Michael J. Overman, Jean‐Nicolas Vauthey, Robert A. Wolff, Miguel A. Rodrı́guez-Bigas, John M. Skibber, Prajnan Das, Eddie K. Abdalla and Steven A. Curley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Cathy Eng

381 papers receiving 15.9k citations

Hit Papers

Improved Survival in Meta... 2005 2026 2012 2019 2009 2006 2005 2008 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
    2009 1.0k citations Scott Kopetz, George J. Chang et al. Journal of Clinical Oncology profile →
  2. Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
    2006 941 citations Jean‐Nicolas Vauthey, Cathy Eng et al. Journal of Clinical Oncology profile →
  3. Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases
    2005 815 citations Eddie K. Abdalla, Cathy Eng et al. profile →
  4. EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
    2008 726 citations Alberto Sobrero, Cathy Eng et al. Journal of Clinical Oncology profile →
  5. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group
    2020 468 citations Robert A. Wolff, Cathy Eng et al. The Oncologist profile →
  6. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 397 citations Cathy Eng et al. Journal of Clinical Oncology profile →
  7. Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
    2012 379 citations Miguel A. Rodrı́guez-Bigas, Cathy Eng et al. Journal of Clinical Oncology profile →
  8. Antiemetics: ASCO Guideline Update
    2020 224 citations Cathy Eng et al. Journal of Clinical Oncology profile →
  9. Colorectal cancer
    2024 126 citations Cathy Eng, Takayuki Yoshino et al. profile →
  10. Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
    2025 34 citations Scott Kopetz, Takayuki Yoshino et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Cathy Eng 10.8k 6.3k 4.2k 3.9k 2.2k 409 16.2k
Axel Grothey 14.2k 1.3× 3.5k 0.6× 3.3k 0.8× 4.9k 1.3× 2.7k 1.2× 331 18.6k
Michael J. Overman 11.2k 1.0× 3.9k 0.6× 2.3k 0.5× 3.9k 1.0× 2.6k 1.2× 447 16.5k
Aimery de Gramont 20.1k 1.9× 5.3k 0.8× 4.7k 1.1× 6.8k 1.8× 2.6k 1.2× 333 25.0k
Dirk Arnold 11.4k 1.0× 6.9k 1.1× 1.9k 0.5× 6.7k 1.7× 1.6k 0.7× 271 17.0k
Werner Scheithauer 14.5k 1.3× 4.1k 0.7× 4.6k 1.1× 5.4k 1.4× 2.2k 1.0× 350 18.2k
Ian Chau 13.1k 1.2× 5.4k 0.9× 3.2k 0.8× 7.2k 1.9× 2.6k 1.2× 473 18.8k
Hans‐Joachim Schmoll 9.8k 0.9× 7.5k 1.2× 1.5k 0.4× 4.6k 1.2× 3.7k 1.7× 541 19.2k
Andrés Cervantes 18.1k 1.7× 8.4k 1.3× 3.8k 0.9× 9.4k 2.4× 4.2k 1.9× 468 27.8k
Alfredo Falcone 13.6k 1.3× 3.0k 0.5× 3.7k 0.9× 5.8k 1.5× 4.6k 2.1× 613 18.9k
Bernard Nordlinger 14.9k 1.4× 8.0k 1.3× 9.4k 2.2× 5.6k 1.4× 2.1k 0.9× 266 21.5k

Countries citing papers authored by Cathy Eng

Since Specialization
Citations

This map shows the geographic impact of Cathy Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Eng more than expected).

Fields of papers citing papers by Cathy Eng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Eng. The network helps show where Cathy Eng may publish in the future.

Co-authorship network of co-authors of Cathy Eng

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Eng. A scholar is included among the top collaborators of Cathy Eng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Eng. Cathy Eng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciombor, Kristen K., Lianchun Xiao, Enrica Marmonti, et al.. (2026). NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. Journal of Clinical Oncology. 44(6). 497–507.
2.
3.
4.
Bekaii‐Saab, Tanios, Arvind Dasari, Cathy Eng, et al.. (2024). Efficacy and safety of fruquintinib in patients with metastatic colorectal cancer according to prior treatment sequence in the refractory setting: Results from FRESCO and FRESCO-2.. Journal of Clinical Oncology. 42(16_suppl). 3579–3579.
5.
Ciombor, Kristen K., Jennifer G. Whisenant, Gregory D. Ayers, et al.. (2023). P-187 Targeting glutamine metabolism and EGFR in RAS wildtype colorectal cancer. Annals of Oncology. 34. S82–S82. 1 indexed citations
6.
Kelly, Ronan J., Katherine M. Bever, Joseph Chao, et al.. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006658–e006658. 14 indexed citations
7.
Santos, Edgardo S., Thomas K. Oliver, Christina Lacchetti, et al.. (2023). Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments. JCO Oncology Practice. 20(1). 19–32. 5 indexed citations
8.
Holowatyj, Andreana N., Wanqing Wen, Timothy E. Gibbs, et al.. (2022). Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal Cancer. Cancer Discovery. 13(3). 570–579. 30 indexed citations
9.
Lieu, Christopher H., Erica A. Golemis, Ilya G. Serebriiskii, et al.. (2019). Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Clinical Cancer Research. 25(19). 5852–5858. 135 indexed citations
10.
Hess, Kenneth R., Filip Jankú, Nora Sánchez, et al.. (2019). Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer. Clinical Cancer Research. 26(8). 1924–1931. 40 indexed citations
11.
Hong, David S., Kathleen N. Moore, Manish R. Patel, et al.. (2018). Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma. Clinical Cancer Research. 24(14). 3263–3272. 62 indexed citations
12.
Parseghian, Christine M., Nila U. Parikh, Ji Yuan Wu, et al.. (2017). Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(15). 4146–4154. 47 indexed citations
13.
Loree, Jonathan M., Allan Andresson Lima Pereira, Michael Lam, et al.. (2017). Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes. Clinical Cancer Research. 24(5). 1062–1072. 201 indexed citations
14.
Morris, Van K., Xiayu Rao, Curtis R. Pickering, et al.. (2017). Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal. Molecular Cancer Research. 15(11). 1542–1550. 50 indexed citations
15.
Holliday, Emma B., Y. Nancy You, George J. Chang, et al.. (2017). Short-Course Radiation As a Component of Definitive Multidisciplinary Treatment for Select Patients with Metastatic Rectal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 99(2). E154–E155. 5 indexed citations
16.
Bailey, Howard H., Linus Chuang, Nefertiti C. duPont, et al.. (2016). American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention. Journal of Clinical Oncology. 34(15). 1803–1812. 60 indexed citations
17.
Cutsem, Eric Van, Cathy Eng, Elżbieta Nowara, et al.. (2014). Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer. Clinical Cancer Research. 20(16). 4240–4250. 92 indexed citations
18.
Lin, Moubin, Jian Gu, Cathy Eng, et al.. (2012). Genetic Polymorphisms in MicroRNA-Related Genes as Predictors of Clinical Outcomes in Colorectal Adenocarcinoma Patients. Clinical Cancer Research. 18(14). 3982–3991. 56 indexed citations
19.
Brouquet, Antoine, Eddie K. Abdalla, Scott Kopetz, et al.. (2011). High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome. Journal of Clinical Oncology. 29(8). 1083–1090. 272 indexed citations
20.
Pecot, Chad V., Farideh Z. Bischoff, Julie Ann Mayer, et al.. (2011). A Novel Platform for Detection of CK+ and CK− CTCs. Cancer Discovery. 1(7). 580–586. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Axel Grothey Breakdown of academic impact, for papers by Michael J. Overman Breakdown of academic impact, for papers by Aimery de Gramont Breakdown of academic impact, for papers by Dirk Arnold Breakdown of academic impact, for papers by Werner Scheithauer Breakdown of academic impact, for papers by Ian Chau Breakdown of academic impact, for papers by Hans‐Joachim Schmoll Breakdown of academic impact, for papers by Andrés Cervantes Breakdown of academic impact, for papers by Alfredo Falcone Breakdown of academic impact, for papers by Bernard Nordlinger
Rankless by CCL
2026